Article
Dr. Jack Cush reviews the news and journal reports from RheumNow.com. This week news on vaccines, safety of acetaminophen and more.
All News
Article
The American College of Rheumatology (ACR) is calling on Alaska and Montana to seize the opportunity to address critical gaps in rheumatology care by accessing funding from the Rural Health Transformation Program (RHTP), provided by the One Big Beautiful Bill Act (H.R.
Article
Passive documentation of clinic visits using artificial intelligence (AI)-drafted notes was linked to reduced burnout and improved well-being, a survey study from two academic medical centers suggested.
Article
SLE is a complex and potentially life-threatening autoimmune disease. Part of the complexity stems from how it can differ from person to person – giving rise to marked heterogeneity in not only manifestations, but also in disease course and treatment response.
Article
Dr. Jack Cush reviews the news, journal reports, FDA approvals, drug safety, and more from this week.
Article
Sjögren syndrome is now Sjögren disease, according to recommendations stemming from the 2023 International Rome consensus for the nomenclature of Sjögren disease.
Article
The third survey in this series addressed clinician views on future trends (AI), future therapies and lessons learned.
Dr. John Cush
Tweet
My Cancelled Lecture Slides
Dr. Cush records his "Life Lessons (that keep changing) in Rheumatology Lecture.
https://t.co/uqj0J6Ii3e https://t.co/ePLc3xnCsF
Dr. John Cush
Tweet
👩⚕️🧑⚕️ RheumIQ is here.
Each week, challenge yourself with 5 quick questions on the latest in rheumatology.
✅ Fast
✅ Evidence-based
✅ Competitive
➡️ Test your RheumIQ today: https://t.co/OjhbnTjFyZ https://t.co/JrPfPn3N8n
Dr. John Cush
Tweet
September is Rheumatic Disease Awareness Month! ARP president Adam Goode, Encourages Physical Activity During September - exercise, move, & get strong!! https://t.co/HhdnJdvBjR https://t.co/BuqTAMJaqN
Dr. John Cush
Tweet
Gout Education Card for Patients - Info & Rules #1
https://t.co/uppST8OBLZ https://t.co/3Ry3erNJCL
Dr. John Cush
Tweet
Gout Education Card for Patients - Diagnosis & Management #2 https://t.co/uppST8OBLZ https://t.co/sLF5WPeuA5
Aravind Palraj
Tweet
Clinical Rheumatology Thread for Busy GPs:
Post 1
Early inflammatory arthritis(IA): the 3–3–3 rule
•Onset ≤3 months
•Morning stiffness ≥30–60 minutes
•≥3 swollen joints (MCP/MTP common)
If present, manage as IA: urgent rheum referral; NSAIDs if no contraindications. https://t.co/hcoumX1ZVY
Dr. John Cush
Tweet
Medscape overview of Polymyositis has been updated - good click and learn! https://t.co/Utx389l7KP https://t.co/Nx9pPiBsMx
Dr. John Cush
Tweet
The world of rheumatoid arthritis treatment has changed dramatically. What do the experts say about the evolution of biologics and DMARDs over the last 20 years?
Join us for a live webinar, moderated by Dr. Jack Cush, where we'll unpack the results of a nationwide survey.
Tues, https://t.co/pKhuHPwcs0
Dr. John Cush
Tweet
🧠 How well do you know this week’s rheumatology news?
The RheumIQ Weekly Quiz is LIVE!
✅ Test your knowledge
📈 Track your progress
🏆 Climb the leaderboard
🔗 Dive into the source materials
Take the quiz now ➡️ https://t.co/nCfbFLaVDx https://t.co/Dv4pD3Xd0b
Dr. John Cush
Tweet
Teaching You How to Think… (8.15.2025)
Dr. Jack Cush reviews the news, journal reports and press clippings from the past week on RheumNow. Positive results in a Sjogren's trial, to PT or not to PT, and aphorisms to live by.
https://t.co/2MhzjNCUEW https://t.co/Mt9iEAYKsK
Dr. John Cush
Tweet
The Patient Journey with Rheumatic Disease
Oton and colleagues have reviewed the "patient journey" - from symptoms to specialty referral in those diagnosed with rheumatic and musculoskeletal diseases (RMDs). They identify the eight stages along the way and where improvements https://t.co/VY3kB3Ohmp
Dr. John Cush
Tweet
“A physician is judged by the three A’s: ability, availability, and affability.”
- Paul Reznikoff, MD
Dr. John Cush
Tweet
Wondering what rheumatoid arthritis experts think about the future of treatment?
Dr. Jack Cush moderates a special Tuesday Nite Rheumatology session, live at 7 PM ET on August 26th, where experts will dive into a nationwide survey on the evolution of biologics and DMARDs.
Hear https://t.co/afYRarqjvj
